Results 211 to 220 of about 162,694 (348)
Obesity Reviews, EarlyView.ABSTRACT Introduction Weight loss results in reduced energy expenditure (EE) due to body composition alterations (e.g., fat‐free mass and fat mass losses) and mass‐independent adaptations in EE (e.g., hormones). Glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) are indicated for obesity management; however, their effects on EE remain unclear ...
Flavio T. Vieira +8 more
wiley +1 more source
Vasopressor Strategy in Pediatric Sepsis: A Clinical Pharmacology Perspective. [PDF]
J Pediatr Pharmacol TherGreen DJ, Watt KM.
europepmc +1 more source
Editorial: Molecular mechanisms of neuropsychiatric diseases, volume II
Frontiers in Molecular NeuroscienceMónica Moreira-Rodrigues
doaj +1 more source
Sulfation of catecholamines, hypertensive and hypotensive drugs by monkey brain cortex enzymes.
, 1993 Anna Barańczyk‐Kuźma +2 more
openalex +2 more sources
Hindbrain Catecholamine Neurons Modulate the Growth Hormone But Not the Feeding Response to Ghrelin [PDF]
, 2010 Alan J. Emanuel, Sue Ritter
openalex +1 more source
Engineered surface strategies to manage dental implant‐related infections
Periodontology 2000, EarlyView.Abstract When exposed to the oral environment, dental implants, like natural surfaces, become substrates for microbial adhesion and accumulation, often leading to implant‐related infections—one of the main causes of implant failure. These failures impose significant costs on patients, clinicians, and healthcare systems.
João Gabriel S. Souza +7 more
wiley +1 more source
Reference intervals of urinary metanephrines: creatinine ratios in dogs: comparison of acidified and non-acidified samples collected by cystocentesis. [PDF]
J Vet Diagn InvestNiederlender S +3 more
europepmc +1 more source
A case of adrenal ganglioneuroma secreting catecholamines
, 2005 Ho‐Cheol Kang +6 more
openalex +1 more source